Brief: Xintela Starts Clinical Study

Xintela AB

20/09/2022 09:21

Sept 20 (Reuters) - Xintela AB  XINT.ST :
    * STARTS CLINICAL STUDY WITH XSTEM FOR DIFFICULT-TO-HEAL LEG
ULCERS
    * RECRUITMENT OF PATIENTS FOR PHASE I/IIA STUDY FOR
TREATMENT OF
DIFFICULT-TO-HEAL VENOUS LEG ULCERS, WHICH IS CARRIED OUT AT
LINKÖPING UNIVERSITY HOSPITAL, HAS NOW BEGUN
    * PRIMARY GOAL OF STUDY IS TO SHOW THAT TREATMENT IS SAFE
BUT ALSO
THAT XSTEM HAS A POSITIVE EFFECT ON WOUND HEALING
    * EARLY SAFETY AND EFFICACY DATA ARE EXPECTED BEFORE END OF
2022

Source text for Eikon:  ID:nMFN5JC5WF 
Further company coverage:  XINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))